期刊文献+

维生素D在复发性流产中的免疫作用机制与研究进展 被引量:8

The research progress and mechanism of Vitamin D in recurrent miscarriage
下载PDF
导出
摘要 复发性流产(RM)在育龄妇女中的发病率为1%~3%。正常妊娠的维持需要母体对胎儿产生免疫耐受,而免疫耐受机制被破坏且未得到及时治疗,将引起RM。维生素D(VD)已被证明在调节母体-胎儿免疫平衡中发挥重要作用,可促进母体对胎儿发生免疫耐受,维持正常妊娠,已有研究表明,VD含量与RM密切相关。本文就VD在维持妊娠过程中的作用机制及其目前在RM中的研究进展进行综述,为临床治疗因VD缺乏或不足引起的RM奠定基础。 Recurrent miscarriage(RM)refers to a spontaneous abortion that occurs over 2 times before 20 gestational weeks,and its incidence in women of childbearing age is about 1%to 3%.Maintenance of normal pregnancy requires the mother to develop immune tolerance to the fetus.If the immune tolerance mechanism is destroyed and not treated promptly,it will cause RM.Vitamin D(VitD)has been shown to play an important role in regulating immune balance between mother and fetus,promoting maternal immune tolerance to the fetus,and maintaining normal pregnancy.Studies have shown that VitD level is closely related to RM.This article reviews the mechanism of VitD for maintenance of pregnancy and its current research progress in order to providing evidence for clinical treatment of RM caused by lack or deficiency of VitD.
作者 李仁燕 杨学妞 李练兵 马明福 徐晓鸥 LI Renyan;YANG Xueniu;LI Lianbing;MA Mingfu;XU Xiaoou(Key Lab of Birth Defects and Reproductive Health of National Health and Family Planning Commission,Chongqing Population and Family Planning Science and Technology Research Institute,Chongqing,400020;Affiliated Hospital of Chongqing Institute of Population and Family Planning Science and Technology)
出处 《中国计划生育学杂志》 2019年第3期400-403,408,共5页 Chinese Journal of Family Planning
基金 重庆市人口和计划生育科学技术研究院基本科研业务费(CSTC 20171712) 重庆市科委质效激励课题(cstc2018jxjl0271)
关键词 复发性流产 维生素D 免疫耐受 治疗 Recurrent miscarriage Vitamin D Immune tolerance Therapy
  • 相关文献

参考文献8

二级参考文献33

  • 1林其德,周涵春.原因不明性习惯性流产的免疫学诊断与治疗[J].中华妇产科杂志,1993,28(3):143-146. 被引量:41
  • 2林其德,周涵春.复发性流产与自身抗体关系的探讨[J].中华妇产科杂志,1993,28(11):674-677. 被引量:49
  • 3曹泽毅.中华妇产科学(第1版)[M].北京:人民卫生出版社,1999.35-37.
  • 4Jones G,Strugnell SA,DeLuca HF. Current understanding of the molec- ular actions of vitamin D [J]. Physiol Rev, 1998,78(4) : 1193-1231.
  • 5Zehnder D,Evans KN,Kilby MD,et al. The ontogeny of 25-hydroxyv tamin D3 lc-hydroxylase expression in human placenta and de cid [J]. Am J pathol,2002,161 : 105-114. /.
  • 6Pospechova K,Rozehnal V,Stejskalova L,et al. Expression and activity of vitamin D receptor in the human placenta and in choriocarcinoma BeWo and JEG-3 cell lines [J]. Mol Cell Endocrinol,2009,299(2): 178-187.
  • 7Vigan P, Lattuada D, Mangioni S,et al. Cycling and early pregnant en- dometrium as a site of regulated expression of the vitamin D system [J]. J Mol Endoerinol, 2006,36(3 ) : 415-424.
  • 8Yoshizawa T,Handa Y,Uematsu Y,et al. Mice lacking the vitamin D receptor exhibit impaired bone formation ,uterine hypoplasia and growth retardation after weaning [J]. Nat Genet, 1997,16 : 391-396.
  • 9Etten EV, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts [J]. J Steroid Biochem Mol Biol,2005,97 (1-2) : 93-101.
  • 10Adorini L,Penna G,Giarratana N,et al. Dendritic cells as key targets for immunomodulation by vitamin D receptor ligands [J]. J Steroid Bioehem Mol Biol, 2004,80-90( 1-5 ) : 437-441.

共引文献69

同被引文献81

引证文献8

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部